LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT04699773
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LITT — PROCEDUREThis procedure is done under MRI guidance and employs low-powered thermal energy to achieve tumor ablation through coagulation.
- Hypofractionated Radiation Therapy — RADIATIONTreatments will be delivered once daily on consecutive treatment days (typically 5 fractions per week). Radiation therapy simulation is to be performed within 10 days of the LITT procedure.
Study Details
The purpose of this study is to evaluate the treatment regimen of using Laser Interstitial Thermal Therapy (LITT) and Hypo-fractionated Radiation Therapy to treat patients with newly diagnosed gliomas.
Key Dates
- Start date
- Feb 20, 2021
- Status verified
- May 2026
- Primary completion
- Feb 28, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 32 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: LITT with Hypofractionated RTLaser interstitial thermal therapy (LITT) followed by hypo-fractionated radiation therapy, 25Gy/10 fractions.
Primary Outcome Measure
Adverse Events [ Time Frame: 2 years ]
Central Contacts
- Mark Mishra, MD410-328-6080
- Caitlin Eggleston, BS410-328-7586
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | |
| University of Maryland Greenebaum Cancer Center | Baltimore | Maryland | 21201 | Graeme Woodworth, MD (SUB_INVESTIGATOR) |
| UCH Kaufman Cancer Center | Bel Air | Maryland | 21014 | Mark Mishra, MD 410-328-6080 Linda Romar |
| Central Maryland Radiation Oncology | Columbia | Maryland | 21044 | Mark Mishra, MD 410-328-6080 Caitlin Eggleston |
| Baltimore Washington Medical Center | Glen Burnie | Maryland | 21061 | Pilar Strycula |
Find similar trials in Baltimore, MD
By condition
By specialty
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- LITT Followed by Hypofractionated RT for Recurrent GliomasRecruiting · University of Maryland, Baltimore · Baltimore, Maryland
- Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young AdultsPHASE1 · Recruiting · Sabine Mueller, MD, PhD · Birmingham, Alabama
- Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsPHASE1 · Recruiting · Jazz Pharmaceuticals · Bethesda, Maryland